Is a hepatobiliary iminodiacetic acid (HIDA) scan indicated when computed tomography (CT) and ultrasound are negative for gallbladder dysfunction?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

HIDA Scan After Negative CT and Ultrasound

Yes, a HIDA scan is indicated when CT and ultrasound are negative but clinical suspicion for gallbladder dysfunction remains high, particularly in patients with typical biliary-type pain. This recommendation is supported by ACR Appropriateness Criteria guidelines and clinical evidence demonstrating that functional gallbladder disorders can exist despite normal anatomic imaging 1.

Clinical Algorithm for Decision-Making

When HIDA Scan is Most Useful:

For Suspected Functional Gallbladder Disorder (Biliary Dyskinesia):

  • Patient presents with typical biliary colic (postprandial right upper quadrant pain, often triggered by fatty meals)
  • Ultrasound shows no gallstones, wall thickening, or pericholecystic fluid
  • CT scan is negative for acute cholecystitis or alternative diagnoses
  • This is the primary indication for cholecystokinin-stimulated HIDA scan 2

For Suspected Acute Acalculous Cholecystitis:

  • Patient has clinical signs of acute cholecystitis (fever, elevated WBC, RUQ tenderness)
  • Both ultrasound and CT are negative
  • High clinical suspicion persists, especially in critically ill or post-surgical patients
  • HIDA scan can be diagnostic when anatomic imaging fails 3

Standardized HIDA Protocol

When ordering HIDA scan for suspected functional gallbladder disorder, use the consensus-recommended protocol 2:

  • Sincalide (CCK) dose: 0.02 μg/kg infused over 60 minutes
  • Normal gallbladder ejection fraction: ≥38%
  • Abnormal result: <38% suggests gallbladder dyskinesia

Evidence Strength and Nuances

Guideline Support: The ACR Appropriateness Criteria explicitly state that "nuclear medicine hepatobiliary imaging with calculation of the gallbladder ejection fraction after cholecystokinin infusion may be used to diagnose chronic gallbladder disease, partial biliary obstruction, and biliary dyskinesia as a cause of right upper quadrant pain" 1. The Society of Gastrointestinal and Laparoendoscopic Surgeons endorses CCK-augmented HIDA imaging for patients with pain of biliary origin 1.

Important Caveat: The guidelines note that HIDA "may be less useful in patients with atypical symptoms" 1. However, research shows that in patients with atypical symptoms, a positive HIDA scan (low ejection fraction) does predict symptom improvement after cholecystectomy (64% resolution vs. 43% with negative HIDA, p=0.013) 4.

Critical Pitfalls to Avoid

1. Don't Skip HIDA in High Clinical Suspicion Cases

Even when both ultrasound and CT are negative, acute acalculous cholecystitis can still be present. Case reports demonstrate that HIDA can be positive when both anatomic imaging modalities are negative, and delay in diagnosis carries >50% mortality in acute acalculous cholecystitis 3.

2. Patient Selection Matters

HIDA scan has limited utility in patients with typical biliary symptoms when used solely to decide on cholecystectomy—symptom resolution rates are similar regardless of HIDA results (66% positive HIDA vs. 77% negative HIDA, p=0.292) 4. However, it remains valuable for:

  • Confirming functional disorder when diagnosis is uncertain
  • Patients with atypical presentations where additional objective data helps guide management
  • Ruling out acute acalculous cholecystitis in appropriate clinical contexts

3. Consider MRCP as Alternative

If HIDA is unavailable or contraindicated, MRI with MRCP provides superior evaluation of the hepatobiliary system compared to CT, with sensitivity of 85-100% for cholelithiasis/choledocholithiasis 1. MRCP can identify structural causes of biliary obstruction that may be missed on ultrasound and CT.

4. Beware of Overutilization

Recent evidence suggests HIDA may be overutilized 4, 5. In patients meeting Tokyo Guidelines criteria for acute cholecystitis based on clinical and ultrasound findings, HIDA adds limited diagnostic value. A prediction model based on clinical signs (Murphy's sign, RUQ tenderness, ultrasound findings) can identify 36.9% of patients who don't need HIDA to establish acute cholecystitis diagnosis 5.

When to Proceed Directly to Surgery

In well-selected patients with:

  • Typical biliary colic symptoms
  • Negative ultrasound for gallstones
  • No alternative diagnosis on CT
  • Persistent, reproducible symptoms affecting quality of life

Consider proceeding to cholecystectomy without HIDA, as symptom resolution rates are comparable regardless of ejection fraction 4. However, HIDA provides objective documentation that may be valuable for shared decision-making and surgical planning.

Bottom Line

Order HIDA scan when negative CT and ultrasound don't match your clinical suspicion, particularly for functional gallbladder disorder in patients with typical biliary pain or when acute acalculous cholecystitis remains a concern despite negative anatomic imaging. Use the standardized 60-minute CCK infusion protocol with 38% ejection fraction cutoff 2. Consider MRCP as an alternative that may identify structural abnormalities missed by other modalities 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.